Advances in Immune Therapy: Checkpoint Blockade and Radiotherapy

THIS EVENT IS NOT OPEN TO THE PUBLIC.

This CME is jointly provided by the Medical Society of Delaware and the Delaware Society for Oncology.

Presented by: Tara Gangadhar, MD, Assistant Professor of Medicine, Hematology-Oncology Division, Abramson Cancer Center, University of Pennsylvania   

Objectives:

At the conclusion of this activity, participants will be able to:

·         Recognize active immune therapies recently approved for the treatment of advanced cancer;

·         Name immune therapies currently being tested in patients with advanced cancer;

·         Discuss combination therapy approaches being investigated in clinical trials as strategies to overcome resistance to therapy.